Volpara Health Technologies Limited
VPAHF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.1% | 9.3% | 17.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.8% | 77.3% | 76.2% | 73.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10% | -15.6% | -16% | -34.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -22.2% | -24.9% | -31.3% | -57.5% |
| EPS Diluted | -0.016 | -0.016 | -0.019 | -0.03 |
| % Growth | 2.4% | 13.2% | 36.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |